Loading...
The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies
Short interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) are the most clinically advanced oligonucleotide-based platforms. A number of N-acetylgalactosamine (GalNAc)-conjugated siRNAs (GalNAc-siRNAs), also referred to as RNA interference (RNAi) therapeutics, are currently in various sta...
Na minha lista:
| Udgivet i: | Toxicol Pathol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249674/ https://ncbi.nlm.nih.gov/pubmed/30139307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0192623318792537 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|